![]() |
市场调查报告书
商品编码
1984175
NGS资料储存市场:2026-2032年全球市场预测(按储存类型、定序平台、资料类型、部署模式和最终用户划分)NGS Data Storage Market by Storage Type, Sequencing Platform, Data Type, Deployment Mode, End User - Global Forecast 2026-2032 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计到 2025 年,NGS 资料储存市场价值将达到 12.9 亿美元,到 2026 年将成长到 14.2 亿美元,到 2032 年将达到 25.7 亿美元,复合年增长率为 10.31%。
| 主要市场统计数据 | |
|---|---|
| 基准年 2025 | 12.9亿美元 |
| 预计年份:2026年 | 14.2亿美元 |
| 预测年份 2032 | 25.7亿美元 |
| 复合年增长率 (%) | 10.31% |
随着定序活动在科研机构、临床检查室和製药公司研发领域的快速发展,迫切需要重新思考基因组资料的储存、保护和存取方式。不断提高的定序通量和读取长度,以及日益增长的检测资料量和资料保留及可追溯性方面的监管要求,使得资料储存从单纯的营运消耗品转变为影响实验设计、合作模式和洞察时间的策略资产。忽视资料储存的机构将面临资料传输瓶颈、营运复杂性增加和分析速度减慢等问题。
定序资料储存环境正经历一场变革,其驱动力来自定序设备、资料管理软体和部署模式的创新。提高吞吐量和读取长度的设备发展趋势,持续推动可扩展储存和高频宽传输能力的需求。同时,智慧分层、压缩和元资料驱动编配等软体技术的进步,正在减少原始资料收集和下游分析之间的摩擦。这些技术因素的共同作用,正在加速从单一的本地资料孤岛转变为融合边缘、核心和云端元素的更灵活的架构的转变。
2025年关税和贸易调整的实施,为依赖进口储存组件和设备的企业在采购週期、硬体筹资策略和供应商选择方面带来了新的变数。关税变化可能会增加某些硬体类别的相对成本,并改变供应商的经济效益,迫使采购团队重新评估总生命週期成本、供应商多元化以及资本支出和服务模式之间的平衡。为此,许多企业正在加速探索以软体为中心的解决方案,将服务合约、託管储存服务和储存容量扩展与初始硬体采购解耦。
透过分析储存类型、部署模式、最终用户、排序平台和资料类型等方面的细分情况,可以清楚地了解需求和功能的发展方向。就储存类型而言,对于需要本地效能和控制的组织来说,硬体部署仍然至关重要;但对于缺乏内部系统工程能力的组织来说,包括咨询、整合、支援和维护在内的服务正变得越来越重要。专门用于资料压缩、资料管理和资料安全的软体层起到放大器的作用,使现有基础设施能够在无需完全更换硬体的情况下实现更高的有效容量和更强大的管治。
区域趋势在製定储存策略方面发挥决定性作用,美洲、欧洲、中东和非洲以及亚太地区的监管、基础设施和资金筹措环境各不相同。在美洲,成熟的云端运算应用、生物技术领域强劲的私人投资以及先进的研究网络,催生了对可扩展、高效能储存解决方案的强劲需求,这些解决方案需与分析和临床资讯学紧密整合。北美机构通常优先考虑支援互通性、高速资料输出以支援协作计划以及快速容量扩展的服务合约。
序列资料储存领域的竞争格局涵盖了成熟的基础设施供应商、专业的储存软体供应商以及提供託管储存和整合服务的服务公司。硬体供应商在效能、能源效率和模组化方面竞争,而软体供应商则透过先进的压缩演算法、元资料为中心的资料管理以及诸如静态和传输中加密、基于角色的存取控制和审计日誌等安全功能来脱颖而出。服务供应商透过提供咨询和系统整合服务,弥合原始容量与实际运作准备之间的差距,从而发挥日益重要的策略作用。
产业领导者应采取务实且多管齐下的方法,使储存架构与科学研究目标、合规要求和财务限制相契合。首先,应建立清晰的管治和资料生命週期策略,以明确资料保留期限、存取控制和资料来源等方面的要求。这可以确保储存决策以已记录的营运需求为指导,而非随意选择。同时,应重新思考架构,将顺序工作流程对应到储存层级。优先考虑低延迟、高吞吐量的资源,用于即时采集原始资料和进行初步分析;为中间资料分配託管云端储存或物件储存;并在符合监管和可重复性要求的情况下,部署经济高效的冷储存层或磁带,用于长期归檔。
本研究整合了定性和定量信息,以全面了解序列资料储存。调查方法结合了对资深储存架构师、生物资讯学经理和采购负责人的专家访谈,以了解实际操作情况和实施障碍。对长读长和短读长平台储存模式和文件类型的技术评估,有助于分析效能需求和分层策略。来自学术、临床和商业实验室的案例研究,为架构选择和操作权衡提供了实际检验。
高通量定序、不断变化的监管预期以及供应链经济格局的转变,使得储存从单纯的后台功能跃升为对科研和临床成果具有重大影响的战略领域。那些基于管治、分层架构和软体优化,并采取审慎的、分阶段的储存策略的机构,更有能力维持科研效率、保护敏感数据,并应对政策和成本压力。资讯科技、生物资讯学、采购和法务部门之间的策略协作至关重要,以确保储存选择能够提升长期营运韧性,而非仅仅追求短期便利。
The NGS Data Storage Market was valued at USD 1.29 billion in 2025 and is projected to grow to USD 1.42 billion in 2026, with a CAGR of 10.31%, reaching USD 2.57 billion by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.29 billion |
| Estimated Year [2026] | USD 1.42 billion |
| Forecast Year [2032] | USD 2.57 billion |
| CAGR (%) | 10.31% |
The rapid expansion of sequencing activities across research institutions, clinical laboratories, and pharmaceutical R&D has created an urgent need to rethink how genomic data is stored, protected, and accessed. Advances in throughput and read length, combined with increasingly data-rich assays and regulatory demands for retention and traceability, have elevated storage from an operational commodity to a strategic asset that influences experimental design, collaboration models, and time-to-insight. Organizations that treat storage as an afterthought face bottlenecks in data transfer, rising operational complexity, and compromised analytical velocity.
Today's storage environment must reconcile competing imperatives: high-performance access for active analysis, cost-effective archiving for long-term regulatory and scientific reproducibility, robust security to safeguard sensitive patient and proprietary data, and flexible deployment to support distributed collaborations. The evolution of cloud-native architectures, tiered storage approaches, and specialized compression and data management tools is reshaping how institutions architect end-to-end sequencing pipelines. Consequently, storage strategy now plays a central role in enabling scalable, compliant, and economically sustainable genomic workflows.
This introduction frames the report's purpose: to examine technological dynamics, policy shifts, and operational practices that determine how sequencing-generated data is preserved and mobilized. By synthesizing technological developments, procurement considerations, and user needs, the following sections present actionable insights for leaders planning storage investments that align with scientific and commercial objectives.
The landscape for sequencing data storage is undergoing transformative shifts driven by innovations in sequencing instrumentation, data management software, and deployment paradigms. Instrumentation trends that increase throughput and read lengths create a persistent demand for scalable storage and high-bandwidth transfer capabilities, while software advancements such as intelligent tiering, compression, and metadata-driven orchestration reduce friction between raw data acquisition and downstream analytics. Together, these technological vectors are accelerating the shift from monolithic on-premises silos toward more fluid architectures that blend edge, core, and cloud elements.
Concurrently, the maturation of cloud ecosystems has altered procurement and operational models. Organizations are increasingly adopting hybrid approaches that keep latency-sensitive workloads close to compute resources while leveraging cloud capacity for burst analysis and long-term archiving. This hybrid posture allows institutions to optimize total cost of ownership without sacrificing analytical performance. At the same time, rising attention to data sovereignty, privacy, and cross-border collaboration is prompting more nuanced deployment choices and supplier due diligence processes.
Operational practices are also evolving. Data governance frameworks, reproducible pipelines, and standardized data formats have emerged as prerequisites for collaborative science and clinical translation. As a result, storage strategies that integrate policy controls, provenance tracking, and automation enjoy stronger adoption. These transformative shifts collectively demand that stakeholders adopt a forward-looking view of storage as an adaptable platform that underpins research agility and clinical reliability.
The introduction of tariffs and trade adjustments in 2025 has introduced new variables into procurement cycles, hardware sourcing strategies, and vendor selection for organizations reliant on imported storage components and appliances. Tariff changes increase the relative cost of certain hardware categories and may shift vendor economics, prompting procurement teams to revisit total lifecycle costs, supplier diversification, and the balance between capital expenditure and service-based models. In response, many organizations are accelerating explorations of service agreements, managed storage offerings, and software-centric solutions that decouple storage capacity growth from upfront hardware purchases.
Tariffs also influence supplier negotiations and regional sourcing strategies. Organizations that previously relied on single-source procurement for specific appliance models are reconsidering multi-vendor approaches and local distribution partners to mitigate supply-chain volatility. This has spurred renewed interest in modular architectures that allow incremental expansion using components from alternative suppliers, reducing dependency on tariff-affected SKUs. For software and cloud-native solutions, the impact is subtler but still material: increased hardware costs can shift buyer preferences toward subscription models, cloud capacity, and tiered retention strategies that emphasize compression and lifecycle policies.
Regulatory compliance and interoperability concerns further shape responses to tariff-driven cost pressures. Institutions must ensure that cost-optimization measures do not compromise data integrity, provenance, or access controls. As a result, finance, procurement, and scientific leadership are collaborating more closely to align sourcing with operational priorities, ensuring that storage decisions reflect both fiscal prudence and research continuity.
Analyzing segmentation across storage types, deployment modes, end users, sequencing platforms, and data types reveals distinct vectors of demand and capability. When storage type is considered, hardware adoption remains foundational for organizations requiring on-premises performance and control, while services encompassing consulting, integration, and support and maintenance are increasingly critical for institutions that lack in-house systems engineering capacity. Software layers focused on data compression, data management, and data security act as force multipliers, enabling existing infrastructure to deliver higher effective capacity and stronger governance without wholesale hardware replacement.
Deployment mode differentiation highlights how cloud, hybrid, and on-premises strategies map to institutional priorities. Pure cloud approaches provide elasticity and simplified vendor management for teams comfortable with remote governance, whereas hybrid models combine on-premises performance for active workloads with cloud scalability for archival and burst compute. Private cloud variants offer more control for regulated environments, while public cloud platforms enable rapid scaling and integration with managed analytics services.
End-user segmentation underscores varied requirements: academic and research institutes, including government research labs and universities, prioritize flexibility, collaboration, and open standards; healthcare providers such as hospitals and clinics demand stringent privacy controls, auditability, and integration with clinical systems; pharmaceutical and biotechnology companies, spanning biotech SMEs and large pharma, focus on high-throughput integrity, chain-of-custody for IP, and optimized workflows that accelerate drug discovery. Sequencing platform choice also drives storage characteristics: long read systems such as those from Oxford Nanopore and PacBio generate distinct file profiles and access patterns compared with short read technologies from Illumina and MGI, influencing compression strategies, index structures, and compute co-location. Finally, data type segmentation differentiates archived cold storage and tape for long-term retention from processed formats like BAM and VCF used for secondary analysis, and raw formats such as BCL and FASTQ that require rapid ingest pipelines and temporary high-performance storage. Understanding how these segments intersect enables tailored architectures that meet performance, compliance, and cost objectives across diverse use cases.
Regional dynamics play a decisive role in shaping storage strategies, with distinctive regulatory, infrastructure, and funding environments across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, mature cloud adoption, robust private investment in biotech, and advanced research networks create strong demand for scalable, high-performance storage solutions that integrate tightly with analytics and clinical informatics. North American institutions frequently prioritize interoperability, fast data egress for collaborative projects, and service agreements that support rapid capacity expansion.
The Europe, Middle East & Africa region faces a complex mosaic of data sovereignty requirements and heterogeneous infrastructure maturity. Organizations here place a premium on deployment models that support localized control, rigorous privacy safeguards, and vendor solutions that align with multijurisdictional compliance regimes. This drives preference for hybrid architectures and private cloud implementations that can be configured to local regulatory frameworks. Additionally, collaborative consortia and pan-regional research initiatives often necessitate standardized data management practices and provenance tracking.
Asia-Pacific presents a dynamic mix of high-growth markets, substantial sequencing capacity expansion, and varying regulatory frameworks. Rapidly expanding research and clinical genomics programs are increasing demand for both on-premises appliances in regions with constrained connectivity and cloud-native models in areas with robust network infrastructure. Across these regions, regional supply chains, tariff exposure, and local vendor ecosystems shape procurement decisions, making geographically informed sourcing and deployment strategies essential for resilient operations.
The competitive landscape for sequencing data storage encompasses established infrastructure vendors, specialized storage software providers, and service firms that offer managed storage and integration services. Hardware vendors compete on performance, energy efficiency, and modularity, while software suppliers differentiate through advanced compression algorithms, metadata-centric data management, and security features such as encryption at rest and in transit, role-based access controls, and audit logging. Service providers play an increasingly strategic role by delivering consulting and systems integration that bridge the gap between raw capacity and operational readiness.
Partnerships and ecosystem plays are a recurring theme: system integrators and cloud providers are collaborating with sequencing platform manufacturers and bioinformatics software makers to offer validated stacks that reduce time to deployment and operational risk. Vendor openness to interoperability and standards-based APIs accelerates integration with pipeline orchestration tools and laboratory information management systems, which in turn reduces bespoke engineering effort for end users. For procurement teams, vendor evaluation must balance technical fit with support capabilities, certification pathways for clinical use, and demonstrated experience in regulated environments.
Finally, innovation in the vendor community continues to lower barriers to adoption for organizations with limited IT resources by offering managed capacity, data lifecycle automation, and consumption-based pricing models that align cost with usage patterns, allowing science teams to focus on results rather than infrastructure management.
Industry leaders should adopt a pragmatic, multi-pronged approach that aligns storage architecture with scientific objectives, compliance needs, and financial constraints. Begin by establishing clear governance and data lifecycle policies that define retention periods, access controls, and provenance requirements so that storage decisions follow documented operational imperatives rather than ad hoc choices. Simultaneously, conduct an architecture review that maps sequencing workflows to storage tiers: prioritize low-latency, high-throughput resources for active raw-data ingest and primary analysis; designate managed cloud or object storage for intermediate processed data; and implement cost-efficient cold tiers or tape for long-term archival where regulatory and reproducibility needs permit.
Procurement strategies should include supplier diversification, contract terms that protect against tariff-driven volatility, and evaluation of service-based alternatives that transform capital expenses into operational expenditures. Invest in data management software that provides compression, indexing, and metadata-driven automation to maximize usable capacity and streamline retrieval. Strengthen cross-functional collaboration between IT, bioinformatics, legal, and laboratory operations to ensure that storage solutions meet security, performance, and compliance objectives.
Finally, pilot hybrid models that co-locate compute and storage where low latency is critical while leveraging cloud elasticity for peak demand and disaster recovery. Use pilot outcomes to build business cases for broader rollouts, and ensure continuous monitoring of performance, costs, and regulatory posture to adapt strategy as technologies and policies evolve.
This research synthesized qualitative and quantitative inputs to produce a comprehensive perspective on sequencing data storage. The methodology combined expert interviews with senior storage architects, bioinformatics leads, and procurement officers to capture operational realities and adoption barriers. Technical assessments of storage patterns and file profiles across long read and short read platforms informed analysis of performance requirements and tiering strategies. Case studies from academic, clinical, and commercial labs provided real-world validation of architecture choices and operational trade-offs.
Data collection included vendor product literature review and hands-on evaluation of representative storage software, compression tools, and integration capabilities. The research prioritized reproducible evidence such as benchmarked ingest rates, compression efficacy on relevant file types, and documented compliance features. Analytical frameworks focused on aligning storage capabilities with use-case requirements, assessing total lifecycle risks associated with procurement and tariff exposure, and mapping regional regulatory influences to deployment choices.
Throughout, findings were triangulated across multiple sources to reduce bias and ensure that recommendations reflect operational feasibility. Where proprietary data or client-specific concerns arose, anonymized examples were used to illustrate decision pathways without compromising confidentiality. The resulting methodology balances technical rigor with practical applicability for stakeholders planning storage modernization initiatives.
The confluence of high-throughput sequencing, evolving regulatory expectations, and shifting supply-chain economics has elevated storage from a background utility to a strategic domain that materially affects scientific and clinical outcomes. Organizations that adopt intentional, segment-aware storage strategies-grounded in governance, tiered architectures, and software-enabled optimization-will be better positioned to sustain research productivity, protect sensitive data, and respond to policy and cost pressures. Strategic alignment across IT, bioinformatics, procurement, and legal functions is essential to ensure storage choices serve long-term operational resilience rather than short-term convenience.
Across regions and end-user types, the optimal balance between on-premises, hybrid, and cloud approaches depends on performance needs, regulatory constraints, and connectivity realities. Likewise, tariff and supply-chain dynamics underscore the value of flexible procurement and an emphasis on software and service models that minimize exposure to capital cost fluctuations. Ultimately, the organizations that treat storage as a managed, evolving capability-incorporating automation, provenance tracking, and vendor interoperability-will unlock faster insights, reduce risk, and achieve more sustainable operations as sequencing workloads continue to scale.
This concluding perspective underscores the central premise of the report: storage decisions are strategic choices that directly influence the pace of discovery and the viability of clinical translation, and they deserve the same level of governance and investment as the sequencing platforms and analytics pipelines they support.